Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.
about
Practical approach to medical management of glaucomaBrimonidine in the treatment of glaucoma and ocular hypertensionHearing in older adults with exfoliation syndrome/exfoliation glaucoma or primary open-angle glaucomaCombined surgery versus cataract surgery alone for eyes with cataract and glaucomaCombination medical treatment for primary open angle glaucoma and ocular hypertension: a network meta-analysisCombined surgery versus cataract surgery alone for eyes with cataract and glaucomaNeuroprotection for treatment of glaucoma in adultsCyclodestructive procedures for glaucomaCombined surgery versus staged surgery for eyes with cataract and glaucomaNeuroprotection for treatment of glaucoma in adultsInterventions for improving adherence to ocular hypotensive therapyLaser trabeculoplasty for open angle glaucomaInterventions for improving adherence to ocular hypotensive therapyShotgun proteomics reveals specific modulated protein patterns in tears of patients with primary open angle glaucoma naïve to therapyCyclodestructive procedures for refractory glaucomaAmyloidosis in Retinal Neurodegenerative DiseasesSystemic and Ocular Hemodynamic Risk Factors in GlaucomaThe significance of intraocular pressure elevation during sleep-related posturesCombination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focusCritical pathogenic events underlying progression of neurodegeneration in glaucomaRegulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucomaComparison of Treated Mean Intraocular Pressure in Stable Glaucoma with Different Severity in VietnamCurrent status of epibulbar anti-glaucoma drainage devices in glaucoma surgeryThe Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional SurveyA Mutation in LTBP2 Causes Congenital Glaucoma in Domestic Cats (Felis catus)Gaps in Glaucoma care: A systematic review of monoscopic disc photos to screen for glaucomaUpdate in intracranial pressure evaluation methods and translaminar pressure gradient role in glaucoma.Medical Management of Glaucoma in the 21st Century from a Canadian PerspectiveCritical evaluation of latanoprostene bunod in the treatment of glaucomaEffects of Four Formulations of Prostaglandin Analogs on Eye Surface Cells. A Comparative StudyNeuroprotection for treatment of glaucoma in adults.The difference in translaminar pressure gradient and neuroretinal rim area in glaucoma and healthy subjectsIntraocular pressure fluctuations in professional brass and woodwind musicians during common playing conditions.Systematic Review of Educational Interventions to Improve Glaucoma Medication Adherence: an update in 2015Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials.Disease severity in newly diagnosed glaucoma patients with visual field loss: trends from more than a decade of data.Medical management of primary open-angle glaucoma: Best practices associated with enhanced patient compliance and persistency.Are rates of vision loss in patients in English glaucoma clinics slowing down over time? Trends from a decade of dataEstimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data.Central corneal thickness and progression of the visual field and optic disc in glaucoma.
P2860
Q22305449-E111E970-09E3-42D6-9E5D-79EBF80ECCA1Q22305848-0872D8E0-0267-4D26-97ED-23A76EE4A27AQ23913070-140EC9BC-F042-4563-9969-CDF935B6EA83Q24186450-94946271-1624-4484-A7BE-126D34BED7C7Q24192958-985F2880-9607-45D0-8CF3-E806CC5FC773Q24194899-AB68DE0E-DC9B-41D5-BCC3-07791F4F2646Q24200657-20D86BE6-DE5E-41EA-9102-FF8662597DBBQ24234611-6AC010AA-3B52-4F8D-B55B-3B6E5BB280F7Q24235707-6CF4C7CA-F19D-4CA8-A7AC-546BF595ABE0Q24240024-E7B942FF-9CBF-47C4-94FC-22E2C37F1075Q24241641-B6FF61E2-B5AF-4C30-BB5A-A4ABF569A494Q24242939-6E315A34-A581-4091-90E7-FD136120DC8AQ24245942-0C80E5BA-2F51-42D6-A245-CA8032D09ADAQ24338381-21BEE771-3DCE-44EB-A0CC-0A162D70F591Q26471740-78178E14-ABC7-462D-9D70-5274F6CF7061Q26739839-B08B8112-09C0-4BBD-A51F-F16270C7CBCBQ26777829-9D2D53A5-E477-4157-9964-D1687A30B45EQ26825794-F5C1D048-3BD9-43DD-A2C1-E030D43B6F3BQ26830201-6314EB8A-B14E-4B91-8D65-4B3BB859012CQ26859194-AE8ABF20-7296-49C0-9C08-294A6BDEC94BQ26861763-0023D8E5-38F2-4D0B-B48D-992470E0CF62Q27002667-0CD935B2-9042-4198-8073-1C919985EB05Q27024617-BB146DE2-F408-47A3-B955-3D1EAE9B7B79Q27304716-721E8FA2-9292-45CE-A4CD-BD9DC3F30911Q27312146-FEB89AD6-6123-4E3E-BEDA-2411FEB7A1DBQ27345105-1105909C-B122-4A72-840B-4DAA335E817AQ27687604-14379471-43E5-4C6C-89C0-EED8A33ABB3EQ28074316-E2828E16-4C37-4573-83AB-DA90906D20DEQ28077208-CB92D69D-C26F-4199-BA9B-BBE3C0F3C1C0Q28548224-4EB24626-2CB7-44D5-B75C-BAABA47AE3F7Q30238789-1D71EC12-18D7-4F0A-A8B3-25621979625FQ30437810-6CAE75C0-E591-40DD-88F9-09D63B60C3E1Q30552848-B331A643-E5C2-43C0-B01E-543A3DE823DEQ30749049-02E6D44C-2978-47F1-B9A0-8656D8A314F6Q30789570-007DA47C-B57B-4FDF-A73C-6B1AE3B63BCFQ30882123-C2ED2AD4-4BEC-46C1-A6F0-A57BEE89D9F9Q30890274-7B23300D-6E18-4941-8B34-2287747F0BAAQ30990445-BD39FC03-B3D0-4B56-9E19-09EA2BD14D51Q31141723-85A6051B-4FCE-4528-B794-660AFCA8C959Q33219713-79442A9B-E629-40CB-9B20-440D25B19BED
P2860
Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Factors for glaucoma progressi ...... early manifest glaucoma trial.
@ast
Factors for glaucoma progressi ...... early manifest glaucoma trial.
@en
type
label
Factors for glaucoma progressi ...... early manifest glaucoma trial.
@ast
Factors for glaucoma progressi ...... early manifest glaucoma trial.
@en
prefLabel
Factors for glaucoma progressi ...... early manifest glaucoma trial.
@ast
Factors for glaucoma progressi ...... early manifest glaucoma trial.
@en
P2093
P1433
P1476
Factors for glaucoma progressi ...... early manifest glaucoma trial.
@en
P2093
Anders Heijl
Bo Bengtsson
Early Manifest Glaucoma Trial Group
Eugene Komaroff
Leslie Hyman
M Cristina Leske
Mohamed Hussein
P356
10.1001/ARCHOPHT.121.1.48
P407
P577
2003-01-01T00:00:00Z